Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

5-aminolevulinic Acid(ALA)ÀÇ ¹æ±¤ ³» ÁÖÀÔ¿¡ ÀÇÇÑ ¹æ±¤¾ÏÀÇ Photodynamic Diagnosis(PDD) Photodynamic Diagnosis(PDD) following Intravesical Instillation of 5-aminolevulinic Acid(ALA) for Detection of Neoplastic Urothelial Lesions

´ëÇѺñ´¢±â°úÇÐȸÁö 1999³â 40±Ç 7È£ p.886 ~ 890
¼Ò¼Ó »ó¼¼Á¤º¸
È«Á¤Èñ/Jeong Hee Hong ¿øÈ£¼®/Àü¼º¼ö/±è´ë°æ/ÃÖÇÑ¿ë/ä¼öÀÀ/Ho Suk Won/Seong Soo Jeon/Dae Kyung Kim/Han Yong Choi/Soo Eung Chai

Abstract

¼­·Ð
Ç¥À缺¹æ±¤¾Ï¿¡ À־ ºÐÈ­µµ°¡ ¾ÆÁÖ ³ª»Û ÀÌÇü¼º ¿ä·Î»óÇÇ(dysplasia)³ª »óÇdz»¾Ï
(carcinoma situ) µîÀÇ º´º¯ÀÇ À¯¹«´Â ÀÌ Á¾¾çÀÇ Àç¹ßÀ̳ª ÁøÇà¿¡ ¸·´ëÇÑ ¿µÇâÀ» ¹ÌÄ¡´Â ¸Å
¿ì Áß¿äÇÑ ¿¹ÈÄ ÀÎÀÚ·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ¿ä·Î»óÇÇ º´º¯À̳ª ¹Ì¼¼ÇÑ Å©±âÀÇ ¹æ±¤
¾ÏÀº À°¾ÈÀûÀ¸·Î Ư¡ÀûÀÎ ¼Ò°ßÀ» º¸ÀÌÁö ¾Ê´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î ÀϹÝÀûÀÎ ¹æ±¤°æ °Ë»ç·Î ÀÌ
·± º´º¯À» Áø´ÜÇÏ°í ÀýÁ¦Çϱâ¶õ ¿©°£ ¾î·ÆÁö ¾Ê´Ù. µû¶ó¼­ ¿À·¡ ÀüºÎÅÍ ÀÌ·± º´º¯À» ³»½Ã°æ
µîÀ» ÅëÇÏ¿© ½±°Ô ã¾Æ³»¾î Ä¡·áÇØ º¸°íÀÚ ÇÏ´Â ½Ãµµ¿Í ÀÌ¿¡ °üÇÑ ¿¬±¸°¡ È°¹ßÈ÷ ÀÌ·ç¾îÁ®
¿ÔÀ¸¸ç, ÃÖ±Ù¿¡ °¨ÀÛ¹°ÁúÀ» ÀÌ¿ëÇÑ ±¤¿ªÇÐÀûÁø´Ü¹ý(photodynamic diagnosis. PDD)ÀÌ °³¹ßµÇ
¾ú´Ù. PDD¶õ ±¤°¨ÀÛ¹°ÁúÀÌ ÀÏÁ¤ÇÑ ÆÄÀåÀ» °¡Áø ±¤¿ø¿¡ ÀÇÇØ ±¤È°¼ºÈ­ µÇ´Â Ư¼ºÀ» ÀÌ¿ëÇÏ
¿© ƯÁ¤ ¾Ï ¼¼Æ÷¿¡¼­ ¼±ÅÃÀûÀ¸·Î Çü±¤À» ¶ì°Ô ÇÔÀ¸·Î¼­ ¾Ï Á¶Á÷ÀÇ Á¸À縦 Áø´ÜÇÏ´Â ¹æ¹ýÀ¸
·Î¼­, Ãʱ⿡´Â °¨ÀÛ¹°ÁúÀÎ porphyrin ÇÕ¼º¹°Áú, Áï PhotofrinÀ» Ç÷°üÀ» ÅëÇÏ¿© Àü½Å¿¡ Åõ¿©
ÇÑ ÈÄ Çü±¤À» ÀÌ¿ëÇÑ ³»½Ã°æÀ¸·Î ¹æ±¤¾ÏÀÇ À§Ä¡¸¦ ¾Ë¾Æ³»´Â ¹æ¹ýÀÌ ½ÃµµµÇ¾ú´Âµ¥, °¨ÀÛ¹°Áú
ÀÇ Àü½Å Åõ¿©¿¡ µû¸¥ ÇǺÎÀÇ ±¤°¨ÀÛ¹ÝÀÀ°ú ±× ¿Ü ´Ù¸¥ Á¦ÇÑÀû ¿äÀÎ µîÀ¸·Î ÀÎÇÏ¿© ÀÓ»óÀûÀÎ
ÀÀ¿ëÀÌ Á¦ÇѵǾú´Ù. ±×·¯³ª, ÃÖ±Ù ³»Àμº ±¤°¨ÀÛ¹°ÁúÀÎ protoporphyrin(PpIX)ÀÇ Àü±¸ ¹°Áú·Î
¾Ë·ÁÁø 5-aminolevulinic acid(ALA)¸¦ ¹æ±¤ ³»¿¡ ±¹¼ÒÀûÀ¸·Î ÁÖÀÔÇÑ ÈÄ Æ¯¼öÇÏ°Ô Á¦ÀÛµÈ Çü
±¤ ³»½Ã°æÀ» ÅëÇÏ¿© ¹æ±¤¾ÏÀ» Áø´ÜÇÏ´Â »õ·Î¿î Áø´Ü¹ýÀÌ °³¹ßµÇ¾ú´Ù. ALA´Â heme »ýÇÕ¼º
°úÁ¤ ÁßÀÇ ÇÑ Àü±¸¹°Áú·Î, ¿ÜºÎ¿¡¼­ ü³»·Î °ú·® ÁÖÀԵǾúÀ» ¶§ ¼¼Æ÷³»¿¡ ALAÀÇ ´ë»ç»ê¹°
ÀÎ PpD(ÀÌ ÃàÀûµÇ°Ô µÇ¸ç ƯÈ÷ ¼±ÅÃÀûÀ¸·Î ¾Ï ¼¼Æ÷¿¡ ³ôÀº ³óµµ·Î ÃàÀûµÇ´Â Ư¼ºÀÌ ÀÖ´Ù.
º» ¿¬±¸¿¡¼­´Â PDD¸¦ À§ÇÏ¿© ¹æ±¤ ³»¿¡ ALA¸¦ ÁÖÀÔÇÑ ÈÄ Çü±¤ ³»½Ã°æÀ» ÀÌ¿ëÇÏ¿© °æ¿ä
µµ ¹æ±¤¾Ï ÀýÁ¦¼úÀ» ½ÃÇàÇÏ¿´´ø ¹æ±¤¾Ï ȯÀÚ¸¦ ´ë»óÀ¸·Î ¹æ±¤ Á¡¸·ÀÇ ³»½Ã°æÀû ¼Ò°ß, Çü±¤
¼Ò°ß ¹× º´¸®Á¶Á÷ÇÐÀû ¼Ò°ßµéÀ» ¼­·Î ºñ±³ÇÏ¿© ÀϹÝÀûÀÎ ¹æ±¤°æÀ¸·Î´Â ¹ß°ßÇϱ⠾î·Á¿î »ó
Çdz»¾Ï µîÀÇ ¿ä·Î»óÇÇ º´º¯°ú ÃʱâÀÇ ¹Ì¼¼ÇÑ ¹æ±¤¾Ï µîÀÇ Áø´Ü¿¡ À־ PDDÀÇ Áø´ÜÀû °¡
Ä¡¸¦ Æò°¡ÇÏ¿´°í ÀÌ¿Í °°Àº PDDÀÇ ÀÓ»óÀû ÀÇÀǸ¦ ¹àÈ÷°íÀÚ ÇÏ¿´´Ù.

Purpose: Flat urothelial lesions such as high-grade dysplasia and carcinoma in situ
and tiny papillary gladder tumors can be overlooked during the conventional cystoscopy.
PDD is based on the detection of protoporphyrin IX (PpIX)-induced fluorescence in
urothelial cancer epithelium through topical administration of 5-aminolevulinic acid(ALA).
This study attempted to evaluate thedlagnosticefficacyofPDDinurothelialneoplasms.
Materials and Methods: 41 patients with suspicion of bladder cancers were
investigated by fluorescence-assisted transurethral resection. Intravesical Instillation of
ALA was done for PDD 2 hours prior to transurethral resection of bladder tumor A
total of 197 tissue samples were obtained from the fluorescing and non-fluorescing areas
of the bladder. The correlation between fluorescence findings and histopathological
diagnosis were investigated.
Results: All 74 samples which appeared malignant during the conventional cystoscopy
were fluorescened strongly in the red, pathologically confirming the tumor. Additional 33
foci of carcinoma(CIS in 12, Ta in 5, T1 in 12, T2 In 4) which were invisible during
routine cystoscopy could be detected only by PpIX-induced fluorescence. The sensitivity
and specificity can be estimated at 97.0% and 32.3%, respectively. Low specificity may
be due to the insufficient number of random biopsies of the normal bladder wall.
Conclusions: PpIX-induced fluorescence with intravesical instillation of ALA is a
feasible and efficient method for mapping the mucosa in the occult urothelial neoplasms.
PDD might be helpful in complete resection of flat urothelial lesions and tiny papillary
tumors and it would be able to provide helpful information for the appropriate further
treatment.

Å°¿öµå

5-aminolevulinic acid; Photodynamic diagnosis; Bladder tumor;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS